How This Evidence Evolved
Surgical Site Infection Prevention
Bundle compliance reduces infections
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
SSI rate: 9.5% (CHG-alcohol) vs 16.1% (povidone-iodine), p=0.004
SSI rate: no significant difference (RR 0.91, p=0.41) — wound protectors not beneficial
Comprehensive bundle-based SSI prevention recommendations with graded evidence
Integration into clinical practice guidelines and recommendations
29 evidence-based recommendations; bundle implementation approach
Chlorhexidine prep, antibiotic timing, normothermia, glycaemic control as core bundle
Current standard of care and ongoing research directions
Landmark Trials in This Story
Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis
SSI rate: 9.5% (CHG-alcohol) vs 16.1% (povidone-iodine), p=0.004
Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial)
SSI rate: no significant difference (RR 0.91, p=0.41) — wound protectors not beneficial
Executive Summary of the American College of Surgeons/Surgical Infection Society Surgical Site Infection Guidelines-2016 Update
Comprehensive bundle-based SSI prevention recommendations with graded evidence
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3M+ peer-reviewed articles.
Related Evidence
Acute Kidney Injury Prevention
From passive to proactive
Colorectal SurgeryDiverticulitis Surgical Management
From mandatory surgery to antibiotics optional
NeurosurgeryDecompressive Craniectomy in Stroke
A dramatic intervention with evidence
Obstetrics & GynecologyPreeclampsia Aspirin Prevention
Screen and prevent in the first trimester